NCT05745857 Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas Status RECRUITING Phase PHASE2
NCT01794845 Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Status TERMINATED Phase PHASE2
NCT01102231 Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00681876 Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00570674 Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck Status TERMINATED Phase PHASE1/PHASE2
NCT00518193 Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix Status TERMINATED Phase PHASE2